2020
DOI: 10.1182/blood-2020-136739
|View full text |Cite
|
Sign up to set email alerts
|

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Older Adults with Acute Myeloid Leukemia (AML)

Abstract: Introduction AML primarily affects older adults and long-term survival in this group is poor. Despite data showing improvement in outcomes of adults aged<80 with utilization of intensive induction chemotherapy and allogeneic HSCT, these are underutilized. In this study, we report our center experience, focusing on HSCT referral and utilization rates in older adults, as well as the reasons for non-referral and utilization. Methods We performed a retrospective … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles